Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target

Rong Bu, Prashant Bavi, Azhar R Hussain, Zeenath Jehan, Jehad Abubaker, Nasser A Al-Sanea, Alaa S Abduljabbar, Luai H Ashari, Samar J Al-Homoud, Fouad Al-Dayel

Research output: Other contribution

Original languageUndefined/Unknown
PublisherAmerican Association for Cancer Research Inc.
Publication statusPublished - 2011

Cite this

Bu, R., Bavi, P., Hussain, A. R., Jehan, Z., Abubaker, J., Al-Sanea, N. A., Abduljabbar, A. S., Ashari, L. H., Al-Homoud, S. J., & Al-Dayel, F. (2011). Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target. American Association for Cancer Research Inc.